The pro-myogenic environment provided by whole organ scale acellular scaffolds from skeletal muscle
Introduction
A hallmark of biomaterials, an evolving concept recently reviewed by Williams [1], is the in vivo interaction with the host’s biological components. The various strategies used to obtain biomaterials for tissue engineering (TE) applications include allografts produced by the recellularization of previously decellularized tissues. Such allografts are widely used, especially for in vivo replacement of tissues and organs whose spatial organization and biochemical composition are complex. The decellularization of an explanted tissue can be achieved through various approaches, all of which eliminate the cellular compartment and leave a spatially and chemically preserved ECM [2]. These approaches have been successfully used to produce transplantable vessels, skin and cardiac tissues [3], [4], [5]. The ECM is, by definition, nature’s ideal biological scaffold material. Indeed, it is specifically synthesized by the resident cells of each tissue and is obviously biocompatible since host cells produce their own matrix. The ECM also provides a supportive medium for blood or lymphatic vessels and for nerves. As reviewed in detail by Badylak, the ECM possesses all of the characteristics of the ideal tissue-engineered scaffold or biomaterial [6]. However, since complex three-dimensional organization of the structural and functional molecules that make up the ECM has not yet been fully characterized, synthesis of this material cannot be fully reproduced in the laboratory. ECM can be obtained from allogenic or syngenic donors, which may pose the histocompatibility and resorption problems that are typical of allografts. ECM scaffold materials that are resistant to degradation appear to elicit a pro-inflammatory macrophage (M1)-like response, whereas the anti-inflammatory (M2) macrophage phenotype prevails in native ECM scaffold materials, which are consequently readily degraded [7].
Recent advances in skeletal muscle TE have opened new perspectives for the replacement of this tissue in common clinical applications, such as traumatic injury, extended tissue ablation or denervation [8]. Key issues in skeletal muscle TE are the composition and architecture of the ECM of this tissue, which is characterized by a highly ordered and hierarchical organization of muscle fibers. Several attempts have been made to address this issue by seeding fibrillar matrices with myoblasts or myogenic stem cells [8]. Skeletal muscle constructs have been obtained by using the ECM deriving from decellularized tissue. In particular, acellular muscles have been used by Borschel et al. as a substratum for C2C12 myoblast cultures, thus producing constructs capable of longitudinal contractile force upon electrical stimulation [9]. The same authors have obtained vascularized constructs by culturing C2C12 cells in a fibrinogen hydrogel contained within cylindrical silicone chambers and transplanting them around the femoral vessels in isogeneic adult recipient rats [9]. Patches of homologous muscle acellular matrix seeded with autologous myoblasts have been used to repair abdominal wall defects in rodents [10]. Minced muscle replaced in its bed has been shown to effectively regenerate fibers, though such fibers are spatially disorganized probably owing to the loss of ECM spatial orientation [11]. ECM and growth factors deeply affect various aspects of cell behavior, including survival, proliferation and differentiation, and are therefore key issues in TE applications [12]. In both pathological conditions, such as Duchenne’s muscular dystrophy, and healthy conditions, such as after strenuous exercise, skeletal muscle tissue is maintained and repaired through regeneration [13]. As regeneration is strongly influenced by ECM and growth factors, ECM extracts have been used to coat culture dishes to induce muscle differentiation in vitro [14]. The role of growth factors in muscle regeneration has also been investigated in depth both in vitro and in vivo [15], [16], [17]. In order to promote host–donor tissue integration and vascularization, engineered factor VIII-releasing synthetic fibers have been used as a scaffold for myoblast cell culture before transplantation of the constructs into murine recipients [18].
While the generation of a whole functional, bioengineered rodent heart has demonstrated that it is possible to produce highly complex whole organs in vitro [5], a functional, anatomically defined skeletal muscle transplantable in vivo has not yet been produced. Few studies have evaluated and characterized the host immune response to non-autologous ECM scaffold materials. To this purpose, we generated an acellular scaffold from skeletal muscle and transplanted it into syngeneic hosts. This approach allowed us to extensively characterize histocompatibility, bioactivity and integration of acellular scaffolds in a murine model.
Section snippets
Animals
Adult sex-matched BALB/C mice were used throughout this study as both donors and hosts. For specific experiments, adult nude athymic mice (strain NU/NU Crl:NU-Foxn1nu, Charles River, Milano, Italy) were used. Mice were treated according to the guidelines of the Institutional Animal Care and Use Committee. Donor animals were sacrificed before skeletal muscle removal, while host animals were anesthetized before muscle dissection and replacement with the acellular scaffold. The transplantation
Acellular scaffold generation from skeletal muscle
A protocol based on a sequence of incubations in iso-osmotic and then hyposmotic detergent solutions was proposed some years ago to make acellular EDL muscle scaffolds from adult mice [9]. More recently, it has been shown that incubation in 1% SDS in deionized water completely decellularizes a whole murine heart [5]. We applied the latter method to two murine skeletal muscles, the EDL and the TA, which differ above all on account of the disparity in the size of their masses, which are 10 and 40
Discussion
An increasing amount of interest is being expressed in tissue engineering and regenerative medicine as a means of restoring or replacing lost or malfunctioning tissues and organs through the use of cells and biomaterial scaffolds [27]. Adopting a widely used approach, either autologous or heterologous cells are cultured in a biocompatible three-dimensional porous scaffold supplemented with growth factors to regenerate new tissues or organs. The scaffold provides necessary interim support for
Conclusion
Allografts of acellular scaffold derived from a whole skeletal muscle explanted from mice and orthotopically transplanted in wt mice remain stable for several weeks, whilst being colonized by inflammatory and stem cells. Acellular scaffolds per se represent a pro-myogenic environment supporting de novo formation of muscle fibers, likely derived from host cells with myogenic potential. Inflammation by immunosuppressive procedures increases the volume of skeletal muscle fibers, thereby improving
Acknowledgments
We gratefully acknowledge the technical help provided by Carla Ramina and Fabrizio Padula (Sapienza University of Rome) for the confocal and flow cytometry analysis, respectively. We thank Giovanna Marazzi and David Sassoon, who have provided the 370 (anti-PW1) Ab. The authors are also grateful to Dario Rossi for his multimedia advice and expertise. Grant support from the following institution is acknowledged: AFM, Italian MIUR, Sapienza University of Rome to SA; UPMC Emergence to DC.
References (48)
On the nature of biomaterials
Biomaterials
(2009)- et al.
Process development of an acellular dermal matrix (ADM) for biomedical applications
Biomaterials
(2004) - et al.
Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions
Ann Thorac Surg
(2005) The extracellular matrix as a biologic scaffold material
Biomaterials
(2007)- et al.
Homologous muscle acellular matrix seeded with autologous myoblasts as a tissue-engineering approach to abdominal wall-defect repair
Biomaterials
(2005) - et al.
Mouse sectioned muscle regenerates following auto-grafting with muscle fragments: a new muscle precursor cells transfer?
Neurosci Lett
(2008) - et al.
Growth factor binding to the pericellular matrix and its importance in tissue engineering
Adv Drug Deliv Rev
(2007) - et al.
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
Neurobiol Dis
(2008) - et al.
The influence of extracellular matrix derived from skeletal muscle tissue on the proliferation and differentiation of myogenic progenitor cells ex vivo
Biomaterials
(2009) - et al.
Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing co-axial electrospun fibers
Biomaterials
(2011)
Autologous extracellular matrix scaffolds for tissue engineering
Biomaterials
Immune response to biologic scaffold materials
Semin Immunol
Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves
J Struct Biol
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
Exp Hematol
Contribution of mesenchymal progenitor cells to tissue repair in rat cardiac allografts undergoing chronic rejection
J Heart Lung Transplant
Functional skeletal muscle formation with a biologic scaffold
Biomaterials
Bioengineered skin substitutes for the management of burns: a systematic review
Burns
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart
Nat Med
Macrophage activation and polarization
Front Biosci
Engineering skeletal muscle tissue–new perspectives in vitro and in vivo
J Cell Mol Med
Contractile skeletal muscle tissue-engineered on an acellular scaffold
Plast Reconstr Surg
Modulation of caspase activity regulates skeletal muscle regeneration and function in response to vasopressin and tumor necrosis factor
PloS One
Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines
Faseb J
Cited by (98)
Integrating biomaterials and food biopolymers for cultured meat production
2021, Acta BiomaterialiaDecellularized extracellular matrices derived from cultured cells at stepwise myogenic stages for the regulation of myotube formation
2020, Biochimica et Biophysica Acta - Molecular Cell ResearchCitation Excerpt :Recently, dECM derived from muscle has been used for the treatment of volumetric muscle loss and cardiac muscle repair. Some of these dECMs have been tried clinically [47–50]. However, these dECMs are prepared from mature muscle and are similar to the late stage matrices in this study.
- 1
Contributed equally to this work.
- 2
2010 Student Award of the International Society for the Advancement of Cytometry.